Status: current, Defined. Date: 31-Jan 2016. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2641704013 | Efavirenz + emtricitabine + tenofovir (product) | en | Fully specified name | Inactive | Initial character case insensitive | SNOMED CT core |
| 2645811010 | Efavirenz + emtricitabine + tenofovir | en | Synonym | Inactive | Case insensitive | SNOMED CT core |
| 3487303019 | Product containing efavirenz and emtricitabine and tenofovir (medicinal product) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| 3495666018 | Product containing efavirenz and emtricitabine and tenofovir | en | Synonym | Inactive | Case insensitive | SNOMED CT core |
| 3668451014 | Efavirenz and emtricitabine and tenofovir product | en | Synonym | Inactive | Case insensitive | SNOMED CT core |
| 3714602010 | Efavirenz- and emtricitabine- and tenofovir-containing product | en | Synonym | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Efavirenz- and emtricitabine- and tenofovir-containing product | Plays role | Antiretroviral therapeutic role | true | Inferred relationship | Some | ||
| Efavirenz- and emtricitabine- and tenofovir-containing product | Is a | Tenofovir-containing product | false | Inferred relationship | Some | ||
| Efavirenz- and emtricitabine- and tenofovir-containing product | Is a | Efavirenz-containing product | true | Inferred relationship | Some | ||
| Efavirenz- and emtricitabine- and tenofovir-containing product | Is a | Emtricitabine-containing product | false | Inferred relationship | Some | ||
| Efavirenz- and emtricitabine- and tenofovir-containing product | Has active ingredient | Tenofovir disoproxil fumarate | false | Inferred relationship | Some | ||
| Efavirenz- and emtricitabine- and tenofovir-containing product | Has active ingredient | Efavirenz | true | Inferred relationship | Some | 1 | |
| Efavirenz- and emtricitabine- and tenofovir-containing product | Has active ingredient | Emtricitabine | true | Inferred relationship | Some | 2 | |
| Efavirenz- and emtricitabine- and tenofovir-containing product | Is a | Emtricitabine- and tenofovir-containing product | true | Inferred relationship | Some | ||
| Efavirenz- and emtricitabine- and tenofovir-containing product | Has active ingredient | Tenofovir | true | Inferred relationship | Some | 3 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Efavirenz and emtricitabine and tenofovir only product | Is a | True | Efavirenz- and emtricitabine- and tenofovir-containing product | Inferred relationship | Some | |
| Efavirenz 600 mg and emtricitabine 200 mg and tenofovir disoproxil fumarate 300 mg oral tablet | Is a | False | Efavirenz- and emtricitabine- and tenofovir-containing product | Inferred relationship | Some | |
| Efavirenz- and emtricitabine- and tenofovir-containing product in oral dose form | Is a | True | Efavirenz- and emtricitabine- and tenofovir-containing product | Inferred relationship | Some |
This concept is not in any reference sets
FHIR